Medical Devices

A landmark real-world study from England shows maternal RSV vaccination slashes infant hospitalizations, validating a powerful new shield for newborns.

Interim trial data shows IPH5201 plus durvalumab yields pathological complete response rates up to 50%, far surpassing current standards for resectable NSCLC.

New data on ATX-295 reveals a potent attack on unstable tumors, guided by an AI biomarker that could change how we select patients for treatment.

Interim study results suggest a common food product may significantly enhance the effectiveness of modern cancer treatments, heralding a new era of care.

A new partnership between Wilcrest Pharma and healthcare giant Premier, Inc. aims to streamline hazardous drug compounding for thousands of U.S. hospitals.

New clinical consensus on ammonia and scrutiny of a standard antibiotic are creating a perfect storm for Yaqrit's promising new liver disease treatments.

With global regulatory approvals secured, Gilead extends its tender offer for Arcellx, moving closer to acquiring a potential best-in-class CAR T therapy.

With $16M in new funding and landmark trial results, ScreenPoint Medical is poised to redefine breast cancer screening with its powerful AI technology.

Preliminary Q1 data from Auna shows rising demand for specialized care in Peru, Colombia, and Mexico, offering investors a transparent new look.

BioPhotas launches the first FDA-cleared LED mask for acne, wrinkles, and hair loss, aiming to redefine at-home beauty tech with its new MYSTIQUE device.

Early Phase 2 data shows invikafusp alfa plus TRODELVY® yields complete responses in heavily pretreated breast cancer, offering a potential new lifeline.

The ACORYS® system offers a non-invasive, real-time, four-chamber heart view, promising to revolutionize arrhythmia treatment and challenge market leaders.

Byondis presents two novel ADC platforms at AACR 2026, aiming to solve drug resistance and offer hope for patients unresponsive to immunotherapy.

With $36M secured, Orthogon Therapeutics is advancing a first-in-class oral drug for BK virus, offering a new lifeline for transplant patients.

For over a decade, Wake Radiology has backed the Komen Race for the Cure, funding research and expanding access to life-saving breast cancer screenings.

With a $10M offering led by its first customer, HeartBeam is set to commercialize its revolutionary 3D ECG system for remote heart health.

The firm's second consecutive Data Breakthrough Award highlights its success in solving complex, decades-old data challenges for researchers globally.

A new franchise, Trua Senior Living Locators, arrives in North Texas, led by an owner whose personal family struggle now fuels his professional purpose.

Patients, doctors, and researchers unite for a grueling ride across Iceland, raising funds and hope for a future free from multiple myeloma.

Medical advances are increasing organ transplants in Quebec, but with nearly 900 people on the waiting list, experts say major systemic reform is essential.